These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
435 related articles for article (PubMed ID: 23688781)
1. linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer. He W; Cai Q; Sun F; Zhong G; Wang P; Liu H; Luo J; Yu H; Huang J; Lin T Biochim Biophys Acta; 2013 Oct; 1832(10):1528-37. PubMed ID: 23688781 [TBL] [Abstract][Full Text] [Related]
2. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence. Zhang S; Zhong G; He W; Yu H; Huang J; Lin T J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320 [TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA linc-UBC1 is negative prognostic factor and exhibits tumor pro-oncogenic activity in gastric cancer. Hu Y; Pan J; Wang Y; Li L; Huang Y Int J Clin Exp Pathol; 2015; 8(1):594-600. PubMed ID: 25755750 [TBL] [Abstract][Full Text] [Related]
4. Increased levels of the long intergenic non-protein coding RNA POU3F3 promote DNA methylation in esophageal squamous cell carcinoma cells. Li W; Zheng J; Deng J; You Y; Wu H; Li N; Lu J; Zhou Y Gastroenterology; 2014 Jun; 146(7):1714-26.e5. PubMed ID: 24631494 [TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA linc-UBC1 promotes tumor invasion and metastasis by regulating EZH2 and repressing E-cadherin in esophageal squamous cell carcinoma. Niu G; Zhuang H; Li B; Cao G J BUON; 2018; 23(1):157-162. PubMed ID: 29552776 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of the long non-coding RNA, linc-UBC1, is associated with poor prognosis and facilitates cell proliferation, migration, and invasion in colorectal cancer. Gao X; Wen J; Gao P; Zhang G; Zhang G Onco Targets Ther; 2017; 10():1017-1026. PubMed ID: 28260919 [TBL] [Abstract][Full Text] [Related]
7. Linc-UBC1 stimulates the metastasis and progression of ovarian cancer via downregulating p53 level. Liu H; Zeng SY; Xie Y; Fei CQ; Sun L Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1054-1061. PubMed ID: 32096175 [TBL] [Abstract][Full Text] [Related]
8. A novel long noncoding RNA Linc-ASEN represses cellular senescence through multileveled reduction of p21 expression. Lee HC; Kang D; Han N; Lee Y; Hwang HJ; Lee SB; You JS; Min BS; Park HJ; Ko YG; Gorospe M; Lee JS Cell Death Differ; 2020 Jun; 27(6):1844-1861. PubMed ID: 31819156 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma. Wu Y; Zhang L; Zhang L; Wang Y; Li H; Ren X; Wei F; Yu W; Liu T; Wang X; Zhou X; Yu J; Hao X Int J Oncol; 2015; 46(6):2586-94. PubMed ID: 25901533 [TBL] [Abstract][Full Text] [Related]
10. LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer. Wang D; Ding L; Wang L; Zhao Y; Sun Z; Karnes RJ; Zhang J; Huang H Oncotarget; 2015 Dec; 6(38):41045-55. PubMed ID: 26516927 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2. Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439 [TBL] [Abstract][Full Text] [Related]
12. PRC2/EED-EZH2 complex is up-regulated in breast cancer lymph node metastasis compared to primary tumor and correlates with tumor proliferation in situ. Yu H; Simons DL; Segall I; Carcamo-Cavazos V; Schwartz EJ; Yan N; Zuckerman NS; Dirbas FM; Johnson DL; Holmes SP; Lee PP PLoS One; 2012; 7(12):e51239. PubMed ID: 23251464 [TBL] [Abstract][Full Text] [Related]
13. The recruitment of chromatin modifiers by long noncoding RNAs: lessons from PRC2. Davidovich C; Cech TR RNA; 2015 Dec; 21(12):2007-22. PubMed ID: 26574518 [TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis of long noncoding RNA linc-UBC1 expression and prognosis and clinicopathological phenotypes in human cancers. Zhang X; Xie H; Luo M; Liang D; Lao W; Ma W; Lin Y Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):875-884. PubMed ID: 32460560 [TBL] [Abstract][Full Text] [Related]
15. TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y Clin Cancer Res; 2014 Mar; 20(6):1531-41. PubMed ID: 24449823 [TBL] [Abstract][Full Text] [Related]
16. Transcription factor ZNF703 activates linc-UBC1 to stimulate the progression of glioma. Wang J; Zhu LS; Luo Y; Wang CH; Wei YY; Zhou LM Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3183-3189. PubMed ID: 32271436 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of polycomb repressive complex 2 key components EZH2/SUZ12/EED as an unfavorable prognostic marker in cholangiocarcinoma. Wasenang W; Puapairoj A; Settasatian C; Proungvitaya S; Limpaiboon T Pathol Res Pract; 2019 Jul; 215(7):152451. PubMed ID: 31126817 [TBL] [Abstract][Full Text] [Related]
18. Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2. Marín-Béjar O; Marchese FP; Athie A; Sánchez Y; González J; Segura V; Huang L; Moreno I; Navarro A; Monzó M; García-Foncillas J; Rinn JL; Guo S; Huarte M Genome Biol; 2013; 14(9):R104. PubMed ID: 24070194 [TBL] [Abstract][Full Text] [Related]
19. NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2. Hu P; Chu J; Wu Y; Sun L; Lv X; Zhu Y; Li J; Guo Q; Gong C; Liu B; Su S Oncotarget; 2015 Oct; 6(32):32410-25. PubMed ID: 26378045 [TBL] [Abstract][Full Text] [Related]
20. High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer. Li C; Cui Y; Liu LF; Ren WB; Li QQ; Zhou X; Li YL; Li Y; Bai XY; Zu XB Clin Genitourin Cancer; 2017 Oct; 15(5):570-576. PubMed ID: 28648755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]